Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Neurochemical Research|August 1, 1997
Glycosphingolipids as potential diagnostic markers and/or antigens in neurological disordersP Fredman, A LekmanNeurochemistry International|October 7, 1998
A new procedure for determining ganglioside GD3 a potential glial cell activation marker in cerebrospinal fluidA Lekman, P FredmanInfection|July 6, 2000
Cerebrospinal fluid antibodies directed against neuron-associated gangliosides in HIV-1 infectionM Gisslén, A Lekman, P FredmanJournal of Neuroimmunology|June 22, 1999
High levels in serum, but no signs of intrathecal synthesis of anti-sulfatide antibodies in HIV-1 infected individuals with or without central nervous system complicationsM Gisslén, A Lekman, P FredmanActa Paediatrica (Oslo, Norway : 1992)|July 1, 1995
Gangliosides in children with autismA Lekman, O Skjeldal, E Sponheim, et al.Neuropediatrics|September 26, 2001
Cerebrospinal fluid markers in children with cerebral white matter abnormalitiesR Kristjánsdóttir, P Uvebrant, A Lekman, et al.Journal of Neurovirology|April 1, 1997
Increased cerebrospinal fluid ganglioside GM1 concentrations indicating neuronal involvement in all stages of HIV-1 infectionM Gisslén, L Hagberg, G Norkrans, et al.Journal of the Neurological Sciences|February 7, 2013
Increased CSF sulfatide levels and serum glycosphingolipid antibody levels in healthy siblings of multiple sclerosis patientsS Haghighi, A Lekman, S Nilsson, et al.Acta Neurologica Scandinavica|June 29, 2011
Myelin glycosphingolipid immunoreactivity and CSF levels in multiple sclerosisS Haghighi, A Lekman, S Nilsson, et al.Developmental Medicine and Child Neurology|October 10, 1998
Gangliosides in cerebrospinal fluid in children with autism spectrum disordersV Nordin, A Lekman, M Johansson, et al.Pageof 2